Question 1

What are the potential benefits of taking duloxetine compared to a placebo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder clinical trial (NCT00036309). Contact the study team or your healthcare provider for specific answers.

Question 2

How long will I need to participate in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder clinical trial (NCT00036309). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking duloxetine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder clinical trial (NCT00036309). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder clinical trial (NCT00036309). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience a worsening of my depression during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder clinical trial (NCT00036309). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other treatment options I should consider alongside this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder clinical trial (NCT00036309). Contact the study team or your healthcare provider for specific answers.

What this study is about